杨红霞,蒋恒波.倍博特对原发性高血压患者血压变异性的影响.[J].中南医学科学杂志.,2013,41(4):379-381. |
倍博特对原发性高血压患者血压变异性的影响 |
Effects of the Fixed-dose Combination of Valsartan/Amlodipine on Blood Pressure Vari-ability(BPV) of Patients with Primary Hypertension |
投稿时间:2013-04-03 |
DOI: |
中文关键词: 倍博特 原发性高血压 血压变异性 |
英文关键词:fixed-dose combination of Valsartan/Amlodipine primary hypertension blood pressure variability |
基金项目: |
|
摘要点击次数: 1852 |
全文下载次数: 5732 |
中文摘要: |
目的观察倍博特对原发性高血压患者血压变异性的影响。方法将191例原发性高血压患者回顾性分为倍博特组64例,缬沙坦组64例和氨氯地平组63例,给药前和给药8周后,分别动态血压监测各组患者,观察倍博特对血压变异性的影响。结果3组治疗8周后,与治疗前相比,24 h平均收缩压(24 hSBP)、24 h平均舒张压(24 hDBP)、24 h平均收缩压变异性(24 hSBPV)、24 h平均舒张压变异性(24 hDBPV)均明显下降(P<0.05);与缬沙坦组和氨氯地平组比较,倍博特组的24 hSBPV下降显著,差异有显著性(P<0.05),但24 hDBPV的改变不明显((P>0.05)。结论倍博特可以降低原发性高血压患者的收缩压变异性,具有良好的降压作用。 |
英文摘要: |
ObjectiveTo evaluate the effect of the fixed-dose combination of Valsartan/Amlodipine on blood pressure vari-ability(BPV)of patients with primary hypertension.Methods191 patients with primary hypertension were included in this study,which were randomly divided into the fixed-dose combination of Valsartan/Amlodipine,Valsartan and Amlodipine group.Before the treatment and 8 weeks after treatment,the BPV of all the patients was measured by ambulatory blood pressure monitoring.ResultsAt 8 weeks,24-hour systolic blood pressure,24-hour diastolic blood pressure,blood variability of systolic blood pressure and blood variability of diastolic blood pressure decreased significantly (P<0.05) compared with pre-treatment level.Compared with Valsartan and Amlodipine group,blood variability of systolic blood pressure in the fixed-dose combination of Valsartan/Amlodipine group was significantly lower,while blood variability of diastolic blood pressure was similar among three groups after 8 weeks.ConclusionValsartan/Amlodipine has smooth control effect on patients with primary hypertension through lowering the variability of systolic blood pressure. |
查看全文 查看/发表评论 下载PDF阅读器 |
关闭 |
|
|
|